US Food & Drug Administration fully approves Pfizer's Covid-19 vaccine

The US Food and Drug Administration on Monday fully approved Pfizer’s COVID-19 vaccine, a move expected to trigger a new wave of vaccine mandates as the Delta variant batters the country.

FDA’s approval of this vaccine is a milestone as the country continue to battle the Covid-19 pandemic, acting FDA Commissioner Janet Woodcock said in a statement.

While millions of people have already safely received COVID-19



vaccines, the agency recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated.

The COVID vaccine, which may now be marketed under its brand name Comirnaty, is the first to receive full approval.

Tens of millions of shots have already been administered under an emergency use authorization (EUA) that was granted on 11 December 2020.